OUTLOOK THERAPEUTICS INC (OTLK) Financials

$0.66

$0.00 (-0.18%)

As on 11-Sep-2026 16:26EDT

Market cap

$161 Mln

Revenue (TTM)

$-1 Mln

P/E Ratio

--

P/B Ratio

38.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Operating Revenue	-1.16	1.41	0.17	--	--	--
Cost of Revenue	1.11	0.76	0.11	0.04	0.20	0.26
Gross Profit	-2.28	0.66	-0.11	-0.04	-0.20	-0.26
Operating Expenses	53.36	67.72	71.70	53.13	62.87	51.73
Operating Profit (EBIT)	-55.64	-67.06	-71.70	-53.13	-63.07	-51.73
Other Income	--	--	--	--	-0.61	-0.50
Profit before Tax	-62.64	-63.98	-75.36	-58.98	-66.05	-53.16
Provision for Tax	-1.51	-1.55	0.00	0.00	0.00	0.00
Profit after Tax (Net Income)	-61.12	-62.42	-75.37	-58.98	-66.05	-53.16
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-66.05	-53.16

Liabilities ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Shareholder's Funds	-10.39	-32.19	-73.08	-14.44	8.74	4.61
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	7.90	4.96	59.35	0.01	0.06	11.45
Current Liabilities	28.68	45.81	42.55	46.73	19.73	6.75
Total Liabilities	54.86	18.58	28.82	32.30	28.53	22.81

Assets ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Non-Current Assets	3.02	1.20	1.41	1.32	1.01	1.30
Current Assets	23.17	17.39	27.42	30.98	27.52	21.51
Total Assets	54.86	18.58	28.82	32.30	28.53	22.81
Total Debt*	18.43	30.19	29.74	35.56	10.96	11.90
Net Current Assets	-5.51	-28.43	-15.14	-15.75	7.79	14.76

Cashflow ($ Mln)	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Cash From Operating Activities	--	-51.83	-68.79	-42.97	-56.67	-54.25
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	44.98	60.33	48.97	59.59	56.19
Net Cash Inflow / Outflow	--	--	--	--	2.92	1.94

Financials Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Adjusted EPS ($)	-2.40	-2.45	-4.06	-4.53	-6.11	-6.24
Cash EPS ($)	-0.70	-2.45	-4.06	-4.53	-6.09	-6.21
Adjusted Book Value ($)	-0.06	--	--	--	0.81	0.54
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.03	-3.71	-3.30	-5.24	-6.37
Free Cash Flow per Share ($)	--	-2.03	-3.71	-3.30	-5.24	-6.37

Profitability Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
ROCE (%)	--	275.41	678.33	-289.05	-364.89	-377.94
ROE (%)	--	118.61	172.24	2,069.13	-990.02	-1,430.47
ROA (%)	-112.42	-263.36	-246.60	-193.93	-257.32	-249.92
EBIT Margin (%)	5,357.01	-4,505.98	-42,443.72	--	--	--
Net Margin (%)	5,254.81	-4,416.22	-44,301.05	--	10,857.53	10,664.96
Cash Profit Margin (%)	0.05	--	--	--	--	--

Growth Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Revenue Growth (%)	-163.03	7.31	--	--	--	-1.00
EBIT Growth (%)	19.05	11.79	-27.92	12.57	-23.62	-49.34
Net Profit Growth (%)	-40.71	17.17	-27.78	10.70	-24.24	-50.86
EPS Growth (%)	-134.55	0.40	0.10	0.26	0.02	0.14
Book Value Growth (%)	59.46	--	--	--	--	--

Valuation Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Price / Earnings	--	-0.43	-1.31	-0.05	-0.20	-0.35
Price / Book Value	38.42	-0.84	-1.36	-0.20	1.51	4.01
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-4.13	-0.77	207,057.42	-0.27	-0.10	-0.31
Close Price ($)	1.59	1.06	5.34	4.42	24.40	43.40
High Price ($)	3.39	6.98	18.00	40.60	46.20	85.20
Low Price ($)	0.16	0.79	4.34	4.00	13.68	13.64
Market Cap ($ Cr)	160.68	--	--	--	--	--

Solvency Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Debt to Equity	--	-0.94	-0.41	-2.46	1.25	2.58
Short term debt to equity ratio	-1.76	-0.93	-0.40	-2.46	1.25	0.21
Current Ratio	0.81	0.38	0.64	0.66	1.39	3.19
Quick Ratio	0.63	0.31	0.64	--	--	--
Interest Coverage	-18.19	-224.96	-22.87	-22.30	-43.42	-55.79

Operating Efficiency Ratios	TTM	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21	Sep-20	Sep-19	Sep-18	Sep-17	Sep-16
Debtors to sales (%)	-141.36	105.48	--	--	--	--
Asset Turnover	-0.02	0.06	0.01	--	--	--
Receivable days	--	192.62	--	--	--	--
Inventory Days	--	806.10	--	--	--	--
Payable days	--	4,385.22	23,326.75	41,601.90	5,074.60	3,198.54
Cash Conversion Cycle	--	-3,386.50	-23,326.75	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.